These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 521209)

  • 21. Hypothermia induced by centrally administered vasopressin in rats. A structure-activity study.
    Meisenberg G; Simmons WH
    Neuropharmacology; 1984 Oct; 23(10):1195-200. PubMed ID: 6549207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacology of novel analogues of oxytocin and deaminooxytocin: directed methods for the construction of disulfide and trisulfide bridges in peptides.
    Chen L; Zoulíková I; Slaninová J; Barany G
    J Med Chem; 1997 Mar; 40(6):864-76. PubMed ID: 9083475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A ureido group containing analogue of oxytocin comprising eight amino acid residues.
    Bodanszky M; Fagan DT; Walter R; Smith CW
    J Med Chem; 1978 Mar; 21(3):306-8. PubMed ID: 628007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of vasopressin effects on the uterus by a synthetic analogue.
    Akerlund M; Strömberg P; Forsling ML; Melin P; Vilhardt H
    Obstet Gynecol; 1983 Sep; 62(3):309-12. PubMed ID: 6877687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors.
    Pena A; Murat B; Trueba M; Ventura MA; Bertrand G; Cheng LL; Stoev S; Szeto HH; Wo N; Brossard G; Serradeil-Le Gal C; Manning M; Guillon G
    Endocrinology; 2007 Sep; 148(9):4136-46. PubMed ID: 17495006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and some pharmacological properties of [8-L-tryptophan]oxytocin.
    Bodanszky M; Tolle JC; Seto J; Sawyer WH
    J Med Chem; 1980 Nov; 23(11):1259-61. PubMed ID: 7452679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine blood flow and myometrial activity at menstruation, and the action of vasopressin and a synthetic antagonist.
    Hauksson A; Akerlund M; Melin P
    Br J Obstet Gynaecol; 1988 Sep; 95(9):898-904. PubMed ID: 3191063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an immunoassay for glypressin, an N-terminal extended vasopressin analogue.
    Ohlin M; Alkner U
    J Immunoassay; 1988; 9(1):19-36. PubMed ID: 3360920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological activities of a fluorescent photoaffinity analog of vasopressin.
    Buku A; Schwartz IL; Gazis D; Ma CL; Eggena P
    Endocrinology; 1985 Jul; 117(1):196-200. PubMed ID: 3924578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
    Nestor JJ; Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional and systemic haemodynamic effects of some vasopressins: structural features of the hormone which prolong activity.
    Cort JH; Albrecht I; Nováková J; Mulder JL; Jost K
    Eur J Clin Invest; 1975 Apr; 5(2):165-75. PubMed ID: 168085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of high-performance liquid chromatography in the quality control of oxytocin, vasopressin and synthetic analogues.
    Maxl F; Siehr W
    J Pharm Biomed Anal; 1989; 7(2):211-6. PubMed ID: 2488622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electronic and vibrational optical activity of several peptides related to neurohypophyseal hormones: disulfide group conformation.
    Pazderková M; Bednárová L; Dlouhá H; Flegel M; Lebl M; Hlaváček J; Setnička V; Urbanová M; Hynie S; Klenerová V; Baumruk V; Maloň P
    Biopolymers; 2012 Nov; 97(11):923-32. PubMed ID: 22899367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of the intraventricular administration of vasopressin and oxytocin on hypothalamic self stimulation].
    Schwarzberg H; Betschen K; Unger H; Schulz H
    Acta Biol Med Ger; 1978; 37(8):1295-6. PubMed ID: 749465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxytocin analogs with oxygen-containing side chains in position 3.
    Gazis D; Schwartz IL; Cordopatis P; Theodoropoulos D
    Int J Pept Protein Res; 1986 Jun; 27(6):679-84. PubMed ID: 3759339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human memory and neurohypophyseal hormones: opposite effects of vasopressin and oxytocin.
    Fehm-Wolfsdorf G; Born J; Voigt KH; Fehm HL
    Psychoneuroendocrinology; 1984; 9(3):285-92. PubMed ID: 6494382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopressin analogues with selective pressor activity.
    Berde B; Boissonnas RA; Huguenin RL; Stürmer E
    Experientia; 1964 Jan; 20(1):42-3. PubMed ID: 5892275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.